pharmaceutical investing Axsome Therapeutics Announces Positive Outcome of Interim Analysis of STRIDE-1 Phase 3 Trial of AXS-05
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements